Black Diamond Therapeutics and OpenEye Scientific Announce Collaboration to Expand MAP Drug Discovery Platform

NEXT STORY
Amolyt Pharma to Present Phase 1 Clinical Trial Data for Lead Product Candidate AZP-3601 at the American Society for Bone and Mineral Research 2021 Annual Meeting
PREV STORY
Global $957 Billion Pharmaceutical Manufacturing Markets to 2028: Increasing Investment and Funding Programs
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aduro Biotech Announces Appointment of Leading Immunotherapy and Oncology Experts to Scientific Advisory Board

BERKELEY, Calif., Jan. 26, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical ...

author_avatar
NASDAQ Market News

Healthy Extracts Inc. (OTCQB: HYEX) Announces the Addition of Dr. Joel Kahn, Renowned Integrative Cardiologist, to Its Medical Board

author_avatar
NASDAQ Market News

Sarepta Therapeutics Signs Agreement with Hansa Biopharma for Imlifidase

author_avatar
NASDAQ Market News